Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-03-10
1995-08-08
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514182, 552540, 552506, 552522, 552525, C07J 900
Patent
active
054398991
ABSTRACT:
Novel compounds having anti-HIV activity are disclosed along with formulations and methods for treating human immunodeficiency viral infections employing these compounds.
REFERENCES:
patent: 2592036 (1952-04-01), Kaiser et al.
patent: 3684801 (1972-08-01), Breslow et al.
patent: 4343796 (1982-08-01), Groen
patent: 4395408 (1983-07-01), Torelli et al.
patent: 4434218 (1984-01-01), Deraedt et al.
patent: 4942154 (1990-07-01), Durette et al.
patent: 4956355 (1990-09-01), Prendergast
patent: 4970199 (1990-11-01), Durette et al.
patent: 4970212 (1990-11-01), Nowicky
patent: 5039688 (1991-08-01), Lewis
patent: 5077284 (1991-12-01), Loria et al.
Cushman et al., "Inhibition of HIV-1 Integration Protein By Aurintricarboxylic Acid Monomers, Monomer Analogs, and Polymer Fractions", Biochemical and Biophysical Research Communications, 185(1):85-90 (1992).
Cushman et al., "Structural Investigation and Anti-HIV Activities of High Molecular Weight ATA Polymers", J. Org. Chem., 57:7241-7248 (1992).
Wang et al., "Isolation and Structure Elucidation of Low Molecular Weight Components of Aurintricarboxylic Acid (ATA)", J. Org. Chem., 57:3861-3866 (1992).
Cushman et al., "Preparation and Anti-HIV Activities of Aurintricarboxylic Acid Fractions and Analogues: Direct Correlation of Antiviral Potency with Molecular Weight", J. Med. Chem., 1991, 34:329-337 (1991).
Weislow et al., "New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity", Journal of the National Cancer Institute, 81(8):577-86, Apr. 19, 1989.
Cushman et al., "Synthesis and Anti-HIV Activities of Low Molecular Weight Aurintricarboxylic Acid Fragments and Related Compounds", J. of Med. Chem., 34:337-342 (1991).
Buckheit et al., "Characteriation of an HIV-1 Isolate Displaying an Apparent Absence of Virion-Associated Reverse Transcriptase Activity", AIDS Research and Human Retroviruses, 7(3):295-302 (1991).
Hoffman et al., "Characterization of the AIDS-Associated Retrovirus Reverse Transcriptase and Optimal Conditions for Its Detection in Virions", Virology, 147:326-335 (1985).
Cushman et al., "Synthesis of the Covalent Hydrate of the Incorrectly Assumed Structure of Aurintricarboxylic Acid (ATA)", Tetrahedron, 46(5):1491-1498 (1990).
Bose et al., "Transformations of Seroid Ketones Using Phosphonate Carbanions", Transformations of Steroid Ketones, 30:505-509, Feb. 1965.
Cushman Mark
Golebiewski Wieslaw M.
Haugwitz Rudiger D.
Cook Rebecca
Purdue Research Foundation
Richter Johann
The United States of America as represented by the Department of
LandOfFree
Cosalane and related compounds having activity against aids and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cosalane and related compounds having activity against aids and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cosalane and related compounds having activity against aids and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-971270